OMNI BIO PHARMACEUTICAL, INC. company info

CIK 1389870
IRS Number 208097969
State of incorporation CO
Business address 5350 SOUTH ROSLYN
SUITE 400
GREENWOOD VILLAGE
CO
80111
Mail address 5350 SOUTH ROSLYN
SUITE 400
GREENWOOD VILLAGE
CO
80111

Short summary

OMNI BIO PHARMACEUTICAL, INC. is a Colorado company, with head office located at 5350 South Roslyn Greenwood Village, Colorado 80111. In 2014 the company owned a total of 1.03 million USD worth of assets, including 921.89 thousand USD worth of current assets and 110.82 thousand USD worth of non-current assets. 2010 was the year when the company amassed the most assets.

OMNI BIO PHARMACEUTICAL, INC. Income Statement

Name [in Millions USD]200620072008200920102011201220132014Trends
Research and development 0.580.400.300.16
Operating Expenses 8.234.645.721.91
Operating Income (Loss) -8.23-4.64-5.72-1.91
Income Tax Expense (Benefit) 0
Net income -1.10-1.81-4.54-15.48-8.23-5.40-7.45-2.52

OMNI BIO PHARMACEUTICAL, INC. Balance Sheet

Name [in Millions USD]200620072008200920102011201220132014Trends
Cash and cash equivalents 1.143.191.121.260.650.85
Intangible Assets, Net (Excluding Goodwill) 0.060.040.070.060.06
Total assets 3.292.301.680.961.03
Current assets 3.231.171.390.790.92
Non-current assets 0.061.120.850.190.11
Accounts payable 0.180.060.010.00
Total current liabilities 0.500.140.090.471.60
Total liabilities 0.751.401.943.86
Common Stock, Value, Issued 0.030.030.040.040.04
Retained Earnings (Accumulated Deficit) -37.69-44.01

OMNI BIO PHARMACEUTICAL, INC. Cash Flow

Name [in Millions USD]200620072008200920102011201220132014Trends
Net income -1.10-1.81-4.54-15.48-8.23-5.40-7.45-2.52
Depreciation and amortization 0.010.020.00
Amortization of Intangible Assets 0.020.000.00
Depreciation and amortization 0.000.00
Accounts payable -0.000.05-0.05-0.03
Net Cash Provided by (Used in) Operating Activities -1.72-1.61-1.70-1.43
Payments to Acquire Intangible Assets 0.03
Net Cash Provided by (Used in) Investing Activities -20.47
Proceeds from Issuance of Common Stock 3.441.36
Net Cash Provided by (Used in) Financing Activities 0.223.441.451.36
Cash and Cash Equivalents, Period Increase (Decrease) -1.50-0.170.21-0.07